Brazil's patent office proposes IP law reforms to speed prosecution, modernize procedures and address patents, AI, designs, trademarks and biotech.

Evidence-based analysis shows biopharmaceutical patents are not excessive, do not create thickets, and can support timely generic competition and real innovation.

Anvisa’s new note supports biosimilar interchangeability in Brazil, aligning with global practice and reinforcing safeguards for switching and traceability.

Rob Rodrigues surveys Brazil’s patent enforcement landscape, highlighting rapid preliminary injunctions and their impact on multinational patent strategy.

Brazil's Ministry of Health issued a new methodology for valuing technology transfer in PDPs, establishing pricing benchmarks and reimbursement rules for IP.

Brazil’s Health Ministry consolidates PDP technology-transfer pricing criteria, detailing F/BDI components, benchmarks, reimbursement logic, and governance steps.

Program listing for APLI Day 1 Panel 7 on injunctive relief, covering a global perspective for enforcing patents and building portfolios.

Silimed secured a Munich PI against Polytech over EP2581193, halting polyurethane-coated implant manufacture and sales in Germany amid parallel UPC action.

São Paulo Court of Justice reinstated an injunction in a med-tech patent dispute, granting suspensive effect to J&J’s extraordinary appeals against Scitech.

David Medical and its subsidiary face Silag/Johnson & Johnson patent suits in China, with claimed damages raised to RMB 161.26 million.

São Paulo court restored a temporary injunction in Johnson & Johnson v Scitech, reimposing Brazil’s ban on sales of Altus electric staplers.

BRPTO’s 2026 patent landscape maps satellite energy and space propulsion trends, showing Brazil’s growing filings and the dominance of research institutions.

Fulbright Medical’s Shanghai Stock Exchange IPO was terminated after extensive Johnson & Johnson patent litigation, including multiple infringement suits and rising damages claims.

Silimed becomes the first Brazilian UPC claimant, suing Polytech in Hamburg over EP’193 implant technology and seeking pan‑European injunctive relief.

On-demand Global IP Spotlight briefing on Latin America covering AI, SEPs, pharmaceuticals, patent prosecution and oppositions, with takeaways for U.S. stakeholders.

Silimed becomes the first Brazilian claimant at the UPC, suing Polytech in Hamburg over EP2581193 and building on German entitlement wins.

Global settlement of pertuzumab biosimilar disputes across the U.S., UPC, the Netherlands and Brazil, highlighting Brazil’s key validity win and UPC order.

The Brazilian Court of Appeal has upheld a preliminary injunction for ZTE against Samsung, reinforcing patent exclusivity in 5G Standard Essential Patent disputes.

This BRPTO study analyzes 6,300 patent applications to map green innovation in Brazilian agriculture, highlighting biofertilizers and international cooperation.

Recent US lawsuits against AI meeting assistants highlight legal risks regarding voice data consent, offering crucial parallels for Brazil's LGPD framework.

O artigo analisa a Lei nº 15.325/2026 e a formalização do profissional multimídia no Brasil, destacando o reconhecimento jurídico e os desafios práticos.

Brazil’s Law 15,325/2026 recognizes multimedia professionals and influencers but faces criticism for educational requirements and lack of oversight mechanisms.

Learn how the Mercosur–EU agreement may reshape Brazil’s IP landscape, strengthening enforcement and influencing patents, trademarks, designs and trade secrets.